George W Smith

Title: George W. Smith: Innovator in Angiogenesis Research

Introduction

George W. Smith is a notable inventor based in Mason, MI (US). He has made significant contributions to the field of biomedical research, particularly in the study of stress response and angiogenesis. With a total of 2 patents, his work has implications for understanding anxiety and depression.

Latest Patents

Smith's latest patents include a method of inhibiting angiogenesis by the administration of a corticotropin releasing factor receptor 2 agonist. This invention provides transgenic mice deficient in corticotropin releasing factor receptor 2 (CRFR2). These mice are valuable for studying anxiety, depression, and the physiology of the HPA axis. His other patent focuses on corticotropin releasing factor receptor 2 deficient mice, which exhibit increased sensitivity to stress and anxiety-like behavior. These findings highlight the potential for CRFR2 antagonists to stimulate angiogenesis for various treatments.

Career Highlights

George W. Smith is associated with the Research Development Foundation, where he continues to advance his research. His work has garnered attention for its innovative approach to understanding the biological mechanisms underlying stress and anxiety.

Collaborations

Smith has collaborated with notable colleagues, including Wylie Walker Vale, Jr. and Kuo-Fen Lee, who contribute to the research efforts in this field.

Conclusion

George W. Smith's innovative research and patents provide valuable insights into the mechanisms of stress and anxiety, paving the way for potential therapeutic applications. His contributions to the field are significant and continue to influence ongoing research.